Amphastar gets FDA OK to produce heparin in China unit

Amphastar announced that the U.S.FDA granted approval of the company’s abbreviated new drug application supplement for the manufacture of semi-purified heparin at the company’s subsidiary, Amphastar Nanjing Pharmaceuticals and the manufacture of heparin sodium USP at the company’s subsidiary, International Medication Systems, Limited.

https://bit.ly/2Hmaa80